Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-06

Clinical Trial Update: AMZ001 for the Treatment of Knee Osteoarthritis Symptoms [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for AMZ001 in knee osteoarthritis shows completed Phase 2/3 study with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMZ001

Snippet

Sponsor: Amzell | Conditions: Osteoarthritis, Knee | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-10-06